A+ Science AB

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Abbvie växlar upp inom neuro – köper alzheimerföretag

Amerikanska Abbvie köper det Bostonbaserade företaget Aliada Therapeutics med läkemedelskandidater mot alzheimer. Affären blir det tredje stora förvärvet för Ab...

Novo Nordisk cuts ties with Hims & Hers after Wegovy dispute

Novo Nordisk is ending its collaboration with Hims & Hers Health due to concerns about the company’s sales and marketing practices related to the weight-loss drug Wegovy.

ZEISS O-INSPECT duo: The multifunctional measuring machine

ZEISS O-INSPECT duo combines advanced microscopy and metrology for impressive measurement accuracy.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

WuXi AppTec, UK Ltd

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”

The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Higher throughput in less time

Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...

USA:s regering skrotar vaccinavtal med Moderna

Trumpadministrationen har avbrutit ett kontrakt som tilldelats Moderna för den sena utvecklingsfasen av ett fågelinfluensavaccin för människor, samt rätten att ...

Ny nässprej ska hjälpa mot social ångest

Rädsla och ångest inför att tala för en publik är något av det amerikanska läkemedelsföretaget Vistagen vill råda bot på med sin läkemedelskandidat i nässprejsf...

Study: Semaglutide tablet produces weight loss

The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.

“You discover one thing – and then 10 new questions arise”

COVID-19, diabetes, heart disease, and the impact of dog ownership on humans are just some of multitasker Tove Fall’s areas of research. However, her current fo...

Efter Trumps utspel – FDA godkänner behandling för autism

Den amerikanska läkemedelsmyndigheten FDA har inlett en process för att godkänna leukovorin som behandling för vissa personer med autismsymtom.

The key to successful collaboration between industry and academia

Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is the key to successful collaboration?

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

IGN: Marknadsföring av prisvinnande läkemedel var vilseledande

Att framföra att ett läkemedel vunnit ett pris går att tolka som att det är bäst i sin klass, och kan därför vara vilseledande. Det slår Informationsgransknings...

Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis

Free webinar organized by ZEISS.

CTC Clinical Trial Consultants AB

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...